Fotemustine

From Wikipedia, the free encyclopedia

Fotemustine
Systematic (IUPAC) name
diethyl (1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}
ethyl)phosphonate
Identifiers
CAS number 92118-27-9
ATC code L01AD05
PubChem 104799
DrugBank EXPT03300
Chemical data
Formula C9H19ClN3O5P 
Mol. mass 315.691 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Fotemustine is a nitrosourea alkylating agent that is being investigated for use in the treatment of melanoma. A recent study (cited below) has shown that fotemustine produces better response rates and increased survival over dacarbazine, which is considered the "gold standard" for chemotherapy of melanoma.

[edit] External links